Skip to content

Disorder Due Cytochrome P450 Cyp2c9 Variant C1828420

Published: July 22, 2026Updated: August 20, 2026

A genetic variant affecting CYP2C9 enzyme activity influences how the body processes warfarin, NSAIDs, and other medications, potentially affecting dosing needs.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Elevated liver enzymes with standard medications

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Increased medication sensitivity

(metabolic)

Fatigue after taking medications

(nervous system)

Bloating after medication intake

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Alternative anticoagulation strategies

Considering direct oral anticoagulants with minimal CYP2C9 metabolism or non-vitamin K antagonist approaches when pharmacogenomic-guided warfarin dosing is impractical.

medication
2

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Pharmacogenomic-guided warfarin dosing

Using CYP2C9 genotype results combined with clinical algorithms for more accurate warfarin initiation and maintenance dosing to achieve therapeutic INR safely.

monitoring

Additional treatment options

NSAID alternative selection

Selecting NSAIDs with minimal CYP2C9 metabolism or considering topical formulations to minimize systemic effects and drug interaction risks.

medication

Vitamin K consistency management

Maintaining consistent dietary vitamin K intake to reduce warfarin dose variability, working with nutrition services to develop appropriate meal planning strategies.

dietary

Specialist hematology consultation

Referral to hematology or anticoagulation specialists for complex cases requiring multiple CYP2C9-metabolized medications or those with recurrent adverse events.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Disorder Due Cytochrome P450 Cyp2c9 Variant C1828420?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Relling MV, Klein TE, Gammal RS, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2C9 and HLA-B genotypes and phenytoin dosing. Clin Pharmacol Ther. 2020.

guideline2020
2

Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 2C9 and its clinical significance. Curr Drug Metab. 2009.

review2009
3

Tucker CE, James NM, Parker CN, et al. Impact of CYP2C9 genetic variants on warfarin maintenance dose in a diverse cohort. Clin Pharmacol Ther. 2022.

clinical_trial2022
4

Borden BA, Kim AM, Stevens NG, et al. CYP2C9 polymorphisms and non-steroidal anti-inflammatory drug-induced gastrointestinal bleeding: a systematic review and meta-analysis. Pharmacogenomics J. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Disorder Due Cytochrome P450 Cyp2c9 Variant C1828420. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy